188 related articles for article (PubMed ID: 9746971)
21. Strategies for improving compliance in treatment of schizophrenia by using a long-acting formulation of an antipsychotic: clinical studies.
Kane JM
J Clin Psychiatry; 2003; 64 Suppl 16():34-40. PubMed ID: 14680417
[TBL] [Abstract][Full Text] [Related]
22. [Non-extrapyramidal motor side-effects in long-term therapy with neuroleptics: an analysis of 99 patients].
Ginzel I; Hilger E; Barnas C
Wien Klin Wochenschr; 2002 Jan; 114(1-2):38-43. PubMed ID: 12407934
[TBL] [Abstract][Full Text] [Related]
23. Noncompliance in schizophrenia.
Babiker IE
Psychiatr Dev; 1986; 4(4):329-37. PubMed ID: 2883650
[TBL] [Abstract][Full Text] [Related]
24. Schizophrenia: attitudes of patients and professional carers towards the illness and antipsychotic medication.
Rettenbacher MA; Burns T; Kemmler G; Fleischhacker WW
Pharmacopsychiatry; 2004 May; 37(3):103-9. PubMed ID: 15138893
[TBL] [Abstract][Full Text] [Related]
25. A prototype approach toward antipsychotic medication adherence in schizophrenia.
Freudenreich O; Tranulis C
Harv Rev Psychiatry; 2009; 17(1):35-40. PubMed ID: 19205965
[TBL] [Abstract][Full Text] [Related]
26. Nonadherence to antipsychotic treatment in patients with schizophrenic disorders.
Svestka J; Bitter I
Neuro Endocrinol Lett; 2007 Feb; 28 Suppl 1():95-116. PubMed ID: 17262005
[TBL] [Abstract][Full Text] [Related]
27. [Subjective well-being under antipsychotic treatment and its meaning for compliance and course of disease].
Naber D; Lambert M; Karow A
Psychiatr Prax; 2004 Nov; 31 Suppl 2():S230-2. PubMed ID: 15586315
[TBL] [Abstract][Full Text] [Related]
28. Attitudes toward antipsychotic medication: the impact of clinical variables and relationships with health professionals.
Day JC; Bentall RP; Roberts C; Randall F; Rogers A; Cattell D; Healy D; Rae P; Power C
Arch Gen Psychiatry; 2005 Jul; 62(7):717-24. PubMed ID: 15997012
[TBL] [Abstract][Full Text] [Related]
29. [Expert opinion on APAP (prolonged action atypical antipsychotic agents). How to evaluate the quality of observations].
Benoit M; Pon J; Zimmermann MA
Encephale; 2009 Jan; Suppl 3():S87-90. PubMed ID: 19268184
[No Abstract] [Full Text] [Related]
30. Enhancing medication use in schizophrenic patients.
Diamond RJ
J Clin Psychiatry; 1983 Jun; 44(6 Pt 2):7-14. PubMed ID: 6133855
[TBL] [Abstract][Full Text] [Related]
31. Strategies for the long-term treatment of schizophrenia: real-world lessons from the CATIE trial.
Meyer JM
J Clin Psychiatry; 2007; 68 Suppl 1():28-33. PubMed ID: 17286525
[TBL] [Abstract][Full Text] [Related]
32. Factors that influence treatment success in schizophrenia.
Buckley PF
J Clin Psychiatry; 2008; 69 Suppl 3():4-10. PubMed ID: 18533756
[TBL] [Abstract][Full Text] [Related]
33. The relationship between patient satisfaction and treatment outcomes in schizophrenia.
Chue P
J Psychopharmacol; 2006 Nov; 20(6 Suppl):38-56. PubMed ID: 17046986
[TBL] [Abstract][Full Text] [Related]
34. Compliance with refilling prescriptions for atypical antipsychotic agents and its association with the risks for hospitalization, suicide, and death in patients with schizophrenia in Quebec and Saskatchewan: a retrospective database study.
Ward A; Ishak K; Proskorovsky I; Caro J
Clin Ther; 2006 Nov; 28(11):1912-21. PubMed ID: 17213012
[TBL] [Abstract][Full Text] [Related]
35. Medication adherence failure in schizophrenia: a forensic review of rates, reasons, treatments, and prospects.
Young JL; Spitz RT; Hillbrand M; Daneri G
J Am Acad Psychiatry Law; 1999; 27(3):426-44. PubMed ID: 10509942
[TBL] [Abstract][Full Text] [Related]
36. [CUtLASS 1 - Increasing disillusion about 2nd generation neuroleptics].
Steinert T
Psychiatr Prax; 2007 Jul; 34(5):255-7. PubMed ID: 17607643
[No Abstract] [Full Text] [Related]
37. [Information-centered family groups for improving compliance in schizophrenic patients].
Bäuml J; Kissling W; Meurer C; Wais A; Lauter H
Psychiatr Prax; 1991 Mar; 18(2):48-54. PubMed ID: 1676178
[TBL] [Abstract][Full Text] [Related]
38. Understanding and addressing adherence issues in schizophrenia: from theory to practice.
Weiden PJ
J Clin Psychiatry; 2007; 68 Suppl 14():14-9. PubMed ID: 18284273
[TBL] [Abstract][Full Text] [Related]
39. [Assessment of therapeutic adherence using questionnaires in patients with schizophrenia].
István B; Agnes M
Psychiatr Hung; 2006; 21(6):430-6. PubMed ID: 17438660
[TBL] [Abstract][Full Text] [Related]
40. New generation antipsychotic drugs and compliance behaviour.
Voruganti LP; Baker LK; Awad AG
Curr Opin Psychiatry; 2008 Mar; 21(2):133-9. PubMed ID: 18332660
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
